NCT00483730View on ClinicalTrials.gov

Actovegin® Versus Placebo in Patients With Diabetic Polyneuropathy (AV-007-IM)

PHASE3CompletedINTERVENTIONAL

Enrollment

569

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

December 31, 2008

Conditions

Symptomatic Diabetic Peripheral Polyneuropathy

Interventions

DRUG

Deproteinised hemoderivative of calf blood (Actovegin)

Symptomatic diabetic peripheral polyneuropathy

Trial Locations (1)

4000

Nycomed, Roskilde

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Nycomed

INDUSTRY